Publication | Closed Access

Synthesis of 2-aryl-4-(benzimidazol-2-yl)-1,2-dihydro[1,2,4]triazino-[4,5-a]benzimidazol-1-one derivatives with preferential cytotoxicity against carcinoma cell lines

Medicinal ChemistryDerivative (Chemistry)DerivativesEngineeringCarcinoma Cell LinesOrganic ChemistryPharmacologyPharmaceutical ChemistryBiomolecular EngineeringPreferential Cytotoxicity